img

Global Lung Cancer Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lung Cancer Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Lung Cancer Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Lung Cancer Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Man and Woman are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Lung Cancer Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Lung Cancer Vaccine key manufacturers include GlaxoSmithKline, Oncothyreon Incorporation, Eli Lily, ImClone Systems, Boehringer Ingelheim, Merck, Ono Pharmaceutical and CureVac, etc. GlaxoSmithKline, Oncothyreon Incorporation, Eli Lily are top 3 players and held % sales share in total in 2022.
Lung Cancer Vaccine can be divided into Subunit Vaccines, Live Attenuated Vaccines, Conjugate Vaccines and Inactivated Vaccines, etc. Subunit Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Lung Cancer Vaccine is widely used in various fields, such as Man and Woman, etc. Man provides greatest supports to the Lung Cancer Vaccine industry development. In 2022, global % sales of Lung Cancer Vaccine went into Man filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lung Cancer Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Oncothyreon Incorporation
Eli Lily
ImClone Systems
Boehringer Ingelheim
Merck
Ono Pharmaceutical
CureVac
Segment by Type
Subunit Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Inactivated Vaccines
Recombinant Vector Vaccines

Segment by Application


Man
Woman

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Lung Cancer Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Lung Cancer Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Lung Cancer Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Lung Cancer Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Lung Cancer Vaccine introduction, etc. Lung Cancer Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Lung Cancer Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Lung Cancer Vaccine Market Overview
1.1 Lung Cancer Vaccine Product Overview
1.2 Lung Cancer Vaccine Market Segment by Type
1.2.1 Subunit Vaccines
1.2.2 Live Attenuated Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Recombinant Vector Vaccines
1.3 Global Lung Cancer Vaccine Market Size by Type
1.3.1 Global Lung Cancer Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Lung Cancer Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Lung Cancer Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lung Cancer Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Lung Cancer Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Lung Cancer Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Lung Cancer Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Lung Cancer Vaccine Sales Breakdown by Type (2024-2024)
2 Global Lung Cancer Vaccine Market Competition by Company
2.1 Global Top Players by Lung Cancer Vaccine Sales (2024-2024)
2.2 Global Top Players by Lung Cancer Vaccine Revenue (2024-2024)
2.3 Global Top Players by Lung Cancer Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Lung Cancer Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lung Cancer Vaccine Market Competitive Situation and Trends
2.5.1 Lung Cancer Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Lung Cancer Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Lung Cancer Vaccine Market
2.8 Key Manufacturers Lung Cancer Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lung Cancer Vaccine Status and Outlook by Region
3.1 Global Lung Cancer Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Lung Cancer Vaccine Historic Market Size by Region
3.2.1 Global Lung Cancer Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Lung Cancer Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Lung Cancer Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Lung Cancer Vaccine Forecasted Market Size by Region
3.3.1 Global Lung Cancer Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Lung Cancer Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Lung Cancer Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Lung Cancer Vaccine by Application
4.1 Lung Cancer Vaccine Market Segment by Application
4.1.1 Man
4.1.2 Woman
4.2 Global Lung Cancer Vaccine Market Size by Application
4.2.1 Global Lung Cancer Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Lung Cancer Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Lung Cancer Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lung Cancer Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Lung Cancer Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Lung Cancer Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Lung Cancer Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Lung Cancer Vaccine Sales Breakdown by Application (2024-2024)
5 North America Lung Cancer Vaccine by Country
5.1 North America Lung Cancer Vaccine Historic Market Size by Country
5.1.1 North America Lung Cancer Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Lung Cancer Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Lung Cancer Vaccine Sales in Value by Country (2024-2024)
5.2 North America Lung Cancer Vaccine Forecasted Market Size by Country
5.2.1 North America Lung Cancer Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Lung Cancer Vaccine Sales in Value by Country (2024-2034)
6 Europe Lung Cancer Vaccine by Country
6.1 Europe Lung Cancer Vaccine Historic Market Size by Country
6.1.1 Europe Lung Cancer Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Lung Cancer Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Lung Cancer Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Lung Cancer Vaccine Forecasted Market Size by Country
6.2.1 Europe Lung Cancer Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Lung Cancer Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Lung Cancer Vaccine by Region
7.1 Asia-Pacific Lung Cancer Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Lung Cancer Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Lung Cancer Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Lung Cancer Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Lung Cancer Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Lung Cancer Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Lung Cancer Vaccine Sales in Value by Region (2024-2034)
8 Latin America Lung Cancer Vaccine by Country
8.1 Latin America Lung Cancer Vaccine Historic Market Size by Country
8.1.1 Latin America Lung Cancer Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Lung Cancer Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Lung Cancer Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Lung Cancer Vaccine Forecasted Market Size by Country
8.2.1 Latin America Lung Cancer Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Lung Cancer Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Lung Cancer Vaccine by Country
9.1 Middle East and Africa Lung Cancer Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Lung Cancer Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Lung Cancer Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Lung Cancer Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Lung Cancer Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Lung Cancer Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Lung Cancer Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 GlaxoSmithKline Lung Cancer Vaccine Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Oncothyreon Incorporation
10.2.1 Oncothyreon Incorporation Company Information
10.2.2 Oncothyreon Incorporation Introduction and Business Overview
10.2.3 Oncothyreon Incorporation Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Oncothyreon Incorporation Lung Cancer Vaccine Products Offered
10.2.5 Oncothyreon Incorporation Recent Development
10.3 Eli Lily
10.3.1 Eli Lily Company Information
10.3.2 Eli Lily Introduction and Business Overview
10.3.3 Eli Lily Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Eli Lily Lung Cancer Vaccine Products Offered
10.3.5 Eli Lily Recent Development
10.4 ImClone Systems
10.4.1 ImClone Systems Company Information
10.4.2 ImClone Systems Introduction and Business Overview
10.4.3 ImClone Systems Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 ImClone Systems Lung Cancer Vaccine Products Offered
10.4.5 ImClone Systems Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Boehringer Ingelheim Lung Cancer Vaccine Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 Merck
10.6.1 Merck Company Information
10.6.2 Merck Introduction and Business Overview
10.6.3 Merck Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Merck Lung Cancer Vaccine Products Offered
10.6.5 Merck Recent Development
10.7 Ono Pharmaceutical
10.7.1 Ono Pharmaceutical Company Information
10.7.2 Ono Pharmaceutical Introduction and Business Overview
10.7.3 Ono Pharmaceutical Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Ono Pharmaceutical Lung Cancer Vaccine Products Offered
10.7.5 Ono Pharmaceutical Recent Development
10.8 CureVac
10.8.1 CureVac Company Information
10.8.2 CureVac Introduction and Business Overview
10.8.3 CureVac Lung Cancer Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 CureVac Lung Cancer Vaccine Products Offered
10.8.5 CureVac Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lung Cancer Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lung Cancer Vaccine Industrial Chain Analysis
11.4 Lung Cancer Vaccine Market Dynamics
11.4.1 Lung Cancer Vaccine Industry Trends
11.4.2 Lung Cancer Vaccine Market Drivers
11.4.3 Lung Cancer Vaccine Market Challenges
11.4.4 Lung Cancer Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lung Cancer Vaccine Distributors
12.3 Lung Cancer Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Subunit Vaccines
Table 2. Major Company of Live Attenuated Vaccines
Table 3. Major Company of Conjugate Vaccines
Table 4. Major Company of Inactivated Vaccines
Table 5. Major Company of Recombinant Vector Vaccines
Table 6. Global Lung Cancer Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Lung Cancer Vaccine Sales by Type (2024-2024) & (K Units)
Table 8. Global Lung Cancer Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Lung Cancer Vaccine Sales by Type (2024-2024) & (US& Million)
Table 10. Global Lung Cancer Vaccine Market Share in Value by Type (2024-2024)
Table 11. Global Lung Cancer Vaccine Price by Type (2024-2024) & (US$/Unit)
Table 12. Global Lung Cancer Vaccine Sales by Type (2024-2034) & (K Units)
Table 13. Global Lung Cancer Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Lung Cancer Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Lung Cancer Vaccine Sales Market Share in Value by Type (2024-2034)
Table 16. Global Lung Cancer Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Lung Cancer Vaccine Sales by Type (2024-2024) & (K Units)
Table 18. North America Lung Cancer Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Lung Cancer Vaccine Sales (K Units) by Type (2024-2024)
Table 20. Europe Lung Cancer Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Lung Cancer Vaccine Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Lung Cancer Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Lung Cancer Vaccine Sales (K Units) by Type (2024-2024)
Table 24. Latin America Lung Cancer Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Lung Cancer Vaccine Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Lung Cancer Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Lung Cancer Vaccine Sales by Company (2024-2024) & (K Units)
Table 28. Global Lung Cancer Vaccine Sales Share by Company (2024-2024)
Table 29. Global Lung Cancer Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Lung Cancer Vaccine Revenue Share by Company (2024-2024)
Table 31. Global Market Lung Cancer Vaccine Price by Company (2024-2024) & (US$/Unit)
Table 32. Global Lung Cancer Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Lung Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer Vaccine as of 2022)
Table 35. Date of Key Manufacturers Enter into Lung Cancer Vaccine Market
Table 36. Key Manufacturers Lung Cancer Vaccine Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Lung Cancer Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Lung Cancer Vaccine Sales by Region (2024-2024) & (K Units)
Table 40. Global Lung Cancer Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Lung Cancer Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Lung Cancer Vaccine Sales Market Share in Value by Region (2024-2024)
Table 43. Global Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 44. Global Lung Cancer Vaccine Sales by Region (2024-2034) & (K Units)
Table 45. Global Lung Cancer Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Lung Cancer Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Lung Cancer Vaccine Sales Market Share in Value by Region (2024-2034)
Table 48. Global Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Lung Cancer Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Lung Cancer Vaccine Sales by Application (2024-2024) & (K Units)
Table 51. Global Lung Cancer Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Lung Cancer Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Lung Cancer Vaccine Sales Market Share in Value by Application (2024-2024)
Table 54. Global Lung Cancer Vaccine Price by Application (2024-2024) & (US$/Unit)
Table 55. Global Lung Cancer Vaccine Sales by Application (2024-2034) & (K Units)
Table 56. Global Lung Cancer Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Lung Cancer Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Lung Cancer Vaccine Sales Market Share in Value by Application (2024-2034)
Table 59. Global Lung Cancer Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Lung Cancer Vaccine Sales by Application (2024-2024) (K Units)
Table 61. North America Lung Cancer Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Lung Cancer Vaccine Sales by Application (2024-2024) (K Units)
Table 63. Europe Lung Cancer Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Lung Cancer Vaccine Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Lung Cancer Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Lung Cancer Vaccine Sales by Application (2024-2024) (K Units)
Table 67. Latin America Lung Cancer Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Lung Cancer Vaccine Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Lung Cancer Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Lung Cancer Vaccine Sales by Country (2024-2024) & (K Units)
Table 71. North America Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Lung Cancer Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2024)
Table 74. North America Lung Cancer Vaccine Sales by Country (2024-2034) & (K Units)
Table 75. North America Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Lung Cancer Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Lung Cancer Vaccine Sales by Country (2024-2024) & (K Units)
Table 79. Europe Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Lung Cancer Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Lung Cancer Vaccine Sales by Country (2024-2034) & (K Units)
Table 83. Europe Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Lung Cancer Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Lung Cancer Vaccine Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Lung Cancer Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Lung Cancer Vaccine Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Lung Cancer Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Lung Cancer Vaccine Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Lung Cancer Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Lung Cancer Vaccine Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Lung Cancer Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Lung Cancer Vaccine Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Lung Cancer Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Lung Cancer Vaccine Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Lung Cancer Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Lung Cancer Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Lung Cancer Vaccine Sales Market Share in Value by Country (2024-2034)
Table 110. GlaxoSmithKline Company Information
Table 111. GlaxoSmithKline Introduction and Business Overview
Table 112. GlaxoSmithKline Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. GlaxoSmithKline Lung Cancer Vaccine Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Oncothyreon Incorporation Company Information
Table 116. Oncothyreon Incorporation Introduction and Business Overview
Table 117. Oncothyreon Incorporation Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Oncothyreon Incorporation Lung Cancer Vaccine Product
Table 119. Oncothyreon Incorporation Recent Development
Table 120. Eli Lily Company Information
Table 121. Eli Lily Introduction and Business Overview
Table 122. Eli Lily Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Eli Lily Lung Cancer Vaccine Product
Table 124. Eli Lily Recent Development
Table 125. ImClone Systems Company Information
Table 126. ImClone Systems Introduction and Business Overview
Table 127. ImClone Systems Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. ImClone Systems Lung Cancer Vaccine Product
Table 129. ImClone Systems Recent Development
Table 130. Boehringer Ingelheim Company Information
Table 131. Boehringer Ingelheim Introduction and Business Overview
Table 132. Boehringer Ingelheim Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Boehringer Ingelheim Lung Cancer Vaccine Product
Table 134. Boehringer Ingelheim Recent Development
Table 135. Merck Company Information
Table 136. Merck Introduction and Business Overview
Table 137. Merck Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Merck Lung Cancer Vaccine Product
Table 139. Merck Recent Development
Table 140. Ono Pharmaceutical Company Information
Table 141. Ono Pharmaceutical Introduction and Business Overview
Table 142. Ono Pharmaceutical Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Ono Pharmaceutical Lung Cancer Vaccine Product
Table 144. Ono Pharmaceutical Recent Development
Table 145. CureVac Company Information
Table 146. CureVac Introduction and Business Overview
Table 147. CureVac Lung Cancer Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. CureVac Lung Cancer Vaccine Product
Table 149. CureVac Recent Development
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Lung Cancer Vaccine Market Trends
Table 153. Lung Cancer Vaccine Market Drivers
Table 154. Lung Cancer Vaccine Market Challenges
Table 155. Lung Cancer Vaccine Market Restraints
Table 156. Lung Cancer Vaccine Distributors List
Table 157. Lung Cancer Vaccine Downstream Customers
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Cancer Vaccine Product Picture
Figure 2. Global Lung Cancer Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Lung Cancer Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Lung Cancer Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Subunit Vaccines
Figure 6. Global Subunit Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Live Attenuated Vaccines
Figure 8. Global Live Attenuated Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Conjugate Vaccines
Figure 10. Global Conjugate Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Inactivated Vaccines
Figure 12. Global Inactivated Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Recombinant Vector Vaccines
Figure 14. Global Recombinant Vector Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Lung Cancer Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Lung Cancer Vaccine Sales Market Share by Type in 2022 & 2034
Figure 17. North America Lung Cancer Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. North America Lung Cancer Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Europe Lung Cancer Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Europe Lung Cancer Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Latin America Lung Cancer Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Lung Cancer Vaccine Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Lung Cancer Vaccine Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Lung Cancer Vaccine Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Cancer Vaccine Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Lung Cancer Vaccine Revenue in 2022
Figure 29. Lung Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Man
Figure 31. Global Man Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Woman
Figure 33. Global Woman Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Lung Cancer Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Lung Cancer Vaccine Sales Market Share by Application in 2022 & 2034
Figure 36. North America Lung Cancer Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. North America Lung Cancer Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Europe Lung Cancer Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Europe Lung Cancer Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Lung Cancer Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Latin America Lung Cancer Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Lung Cancer Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Lung Cancer Vaccine Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Lung Cancer Vaccine Manufacturing Cost Structure
Figure 47. Lung Cancer Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries